Diabetic cardiomyopathy is the presence of myocardial dysfunction in the absence of
coronary artery disease and hypertension. Hyperglycemia seems to be central to the …

Despite encouraging advances in prevention and treatment of atherothrombosis,
cardiovascular disease (CVD) remains a major cause of deaths and disability worldwide …

Insulin resistance (IR) is the underlying defect in> 90% of patients with type 2 diabetes
mellitus and the major pathologic mechanism for the associated susceptibility to premature …

Background The potential benefit of dual antiplatelet therapy beyond 1 year after a
myocardial infarction has not been established. We investigated the efficacy and safety of …

Background In some randomized trials comparing revascularization strategies for patients
with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than …

Objectives: This study tested the near-term reproducibility of 18fluorodeoxyglucose positron
emission tomography (FDG-PET) imaging of atherosclerosis. Background: It is known that …

Atherosclerosis imaging with 18F-FDG PET is useful for tracking inflammation within plaque
and monitoring the response to drug therapy. Short-term reproducibility of this technique in …

Background: Adherence to evidence-based cardiovascular (CV) medications after an acute
myocardial infarction (MI) is low after the first 6 months. The use of fixed-dose combinations …

Background: Although guideline-recommended therapies reduce major adverse
cardiovascular events (MACE) in patients after myocardial infarction (MI) or those with …

Background—Fluorodeoxyglucose positron-emission tomography (FDG PET) imaging of
atherosclerosis has been used to quantify plaque inflammation and to measure the effect of …